Recent studies in the United States have uncovered a worrying link between both short-term and long-term exposure to fine particulate matter (PM2.5) and a heightened risk of hospital admissions for serious heart and lung diseases. Published in The BMJ, these findings point to a concerning reality: there may be no “safe” level of exposure when it comes to our heart and lung health.
This issue is not just a national concern but a global health emergency. The Global Burden of Disease study reveals that exposure to PM2.5 is responsible for approximately 7.6% of global deaths and 4.2% of disability-adjusted life years, which indicates a significant loss of healthy living years.
Responding to this alarming data, the World Health Organization (WHO) revised its air quality guidelines in 2021. The new standards are quite stringent: the recommended annual average level of PM2.5 should remain below 5 μg/m3, and the 24-hour average should not exceed 15 μg/m3 for more than three to four days in a year.
In a groundbreaking study, researchers analyzed the link between daily PM2.5 levels and the residential locations of almost 60 million older adults in the U.S. from 2000 to 2016. Using Medicare data, they tracked hospital admissions over about eight years. The results were startling. Over three years, average exposure to PM2.5 was tied to a significant increase in hospital admissions for various cardiovascular diseases, including ischemic heart disease and heart failure.
The study found that exposure levels even slightly higher than the WHO’s guidelines were associated with a marked increase in the risk of cardiovascular disease-related hospital admissions. Specifically, exposure to PM2.5 levels between 9 and 10 μg/m3 was linked to a 29% increased risk, compared to the safer levels of 5 μg/m3 or less.
In another comprehensive study, researchers examined the effects of short-term PM2.5 exposure on hospital admissions and emergency department visits across a broad age range. Their findings were equally concerning, showing that even brief exposure to PM2.5 at levels below WHO’s limits significantly increased hospital admissions and emergency visits for natural, cardiovascular, and respiratory reasons.
These studies collectively underscore the urgent need for a re-evaluation of air quality standards. While acknowledging some limitations in their research, the teams emphasize that the implications are too significant to ignore. As the debate on air quality limits continues, these findings serve as a critical reference point for future national standards on air pollution, underscoring the vital need to protect public health from the invisible threat of air pollution.
About Clear Health Pass™
Clear Health Pass™ is a bioinformatics, bio-surveillance, and health diagnostic platform for humans and Pets. Clear Health Pass™ is a minority/veteran-operated organization in partnership as tribal is a portfolio partner of The Native American Venture Fund (NAVF). Clear Health Pass Holdings, LLC, DBA Clear Health Pass™ is an appointed “Tribal Agent” for The Blue Lake Rancheria Economic Development Corporation (BLREDC), a federal, Section 17 Tribal Corporation, whose tribal sovereignty’s authority is derived from The Indian Reorganization Act Of 1934 (IRA), 25 U.S.C. § 477.
If you would like to know more information and investment opportunities with Clear Health Pass™ you can request information via this link